Pizzolo, Francesca

Baricitinib restrains the immune dysregulation in patients with severe COVID-19

Bronte, V., Ugel, S., Tinazzi, E., Vella, A., De Sanctis, F., Canè, S., Batani, V., Trovato, R., Fiore, A., Petrova, V., et al. (2020) · Journal of Clinical Investigation

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 281

Prevalence of Body Iron Excess in the Metabolic Syndrome

Bozzini, C., Girelli, D., Olivieri, O., Martinelli, N., Bassi, A., De Matteis, G., Tenuti, I., Lotto, V., Friso, S., Pizzolo, F., et al. (2005) · Diabetes Care

Iron Metabolism and DisordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 224

Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease

Olivieri, O., Bassi, A., Stranieri, C., Trabetti, E., Martinelli, N., Pizzolo, F., Girelli, D., Friso, S., Pignatti, P. F., & Corrocher, R. (2003) · Journal of Lipid Research

Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 139

ApoC-III gene polymorphisms and risk of coronary artery disease

Olivieri, O., Stranieri, C., Bassi, A., Zaia, B., Girelli, D., Pizzolo, F., Trabetti, E., Cheng, S., Grow, M. A., Pignatti, P. F., et al. (2002) · Journal of Lipid Research

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 70

Apolipoprotein C-III, n-3 polyunsaturated fatty acids, and “insulin-resistant” T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction

Olivieri, O., Martinelli, N., Sandri, M., Bassi, A., Guarini, P., Trabetti, E., Pizzolo, F., Girelli, D., Friso, S., Pignatti, P. F., et al. (2005) · Clinical Chemistry

Fatty Acid Research and HealthLipid metabolism and disorders

Cited by 50